RYVCX | VENAX | RYVCX / VENAX | |
Total Expense Ratio | 2.40 | 0.09 | 2,667% |
Annual Report Gross Expense Ratio | 2.43 | 0.09 | 2,700% |
Fund Existence | 24 years | 21 years | - |
Gain YTD | -14.615 | 0.921 | -1,587% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5M | 8.11B | 0% |
Annual Yield % from dividends | 0.00 | 3.27 | - |
Returns for 1 year | -25.02 | -4.70 | 532% |
Returns for 3 years | 1.65 | 21.52 | 8% |
Returns for 5 years | 75.58 | 146.87 | 51% |
Returns for 10 years | -68.20 | 17.86 | -382% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GCLLX | 16.98 | 0.16 | +0.95% |
Goldman Sachs Enhanced U.S. Equity C | |||
ICPUX | 6.38 | 0.06 | +0.95% |
Integrity Mid-North American Resources C | |||
VITSX | 150.04 | 1.28 | +0.86% |
Vanguard Total Stock Market Idx I | |||
PARWX | 56.17 | 0.32 | +0.57% |
Parnassus Value Equity Investor | |||
JGYIX | 13.02 | 0.06 | +0.46% |
JHancock Global Shareholder Yield I |